EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Virucidal Potential of 3,3′,4,4′,5,5′-Hexahydroxy-trans-Stilbene Against Respiratory Syncytial Virus

Zoltán Bánki iD, Leonie Wolf iD, Brigitte Müllauer, Daniel Geisler-Moroder, Wegene Borena iD, Walter Jäger, Thomas Szekeres iD

Viruses · 2025

DOI: 10.3390/v17101287 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2025. Verfasst von Zoltán Bánki und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Virology, Medical University of Innsbruck, 6020 Innsbruck, Austria. Hauptthemen laut MEDLINE: Antiviral Agents, Stilbenes, Respiratory Syncytial Virus, Human. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Respiratory syncytial virus (RSV) infections have a significant impact on global health. Despite of recent advancements, the current treatment options for managing severe RSV infections remain primarily limited to supportive care, emphasizing the high priority for the development of effective antiviral therapies. Antiviral activity of 3,3′,4,4′,5,5′-hexahydroxy-trans-stilbene (HHS), a synthetic polyhydroxyphenol, has previously been demonstrated against SARS-CoV-2. In this study, we provide evidence for a direct virucidal effect of HHS against RSV infection in permissive HEp-2 cells in vitro. HHS, with an IC50 of 3.44 μM, efficiently inhibited HEp-2 cell infection with no sign of toxicity at least up to 25 μM. Interestingly, resveratrol, a polyhydroxyphenol analogue, was less efficient. Mode of action experiments revealed that HHS directly interacts with RSV particles, indicating that its virucidal activity is based on this interaction rather than affecting HEp-2 cells or post-infection processes. Together with previous data, our results suggest a broad antiviral activity of HHS against different respiratory viruses. Further studies are necessary to unveil the exact mechanism and evaluate the potential of HHS in the treatment of severe respiratory virus infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsStilbenesRespiratory Syncytial Virus, HumanHumansCell LineRespiratory Syncytial Virus InfectionsVirus Replication

Stichwörter der Autor:innen

antiviralspolyhydroxyphenolrespiratory syncytial virus

Substanzen

Antiviral AgentsStilbenes

Autor:innen und Institutionen

  • Institute of Virology, Medical University of Innsbruck, 6020 Innsbruck, Austria.
  • Department of Pharmaceutical Sciences, Division of Pharmaceutical Chemistry, University of Vienna, 1090 Vienna, Austria.
  • Department of Laboratory Medicine, Medical University of Vienna, 1090 Vienna, Austria.

ORCID-Profile: Zoltán Bánki, Leonie Wolf, Wegene Borena, Thomas Szekeres

Zitieren

APA

Bánki, Z., Wolf, L., Müllauer, B., Geisler-Moroder, D., Borena, W., Jäger, W., & Szekeres, T. (2025). Virucidal Potential of 3,3′,4,4′,5,5′-Hexahydroxy-trans-Stilbene Against Respiratory Syncytial Virus. Viruses. https://doi.org/10.3390/v17101287

Vancouver

Bánki Z, Wolf L, Müllauer B, Geisler-Moroder D, Borena W, Jäger W, et al. Virucidal Potential of 3,3′,4,4′,5,5′-Hexahydroxy-trans-Stilbene Against Respiratory Syncytial Virus. Viruses. 2025. doi:10.3390/v17101287

BibTeX
@article{Bnki2025,
  author = {Bánki, Zoltán and Wolf, Leonie and Müllauer, Brigitte and Geisler-Moroder, Daniel and Borena, Wegene and Jäger, Walter and Szekeres, Thomas},
  title = {Virucidal Potential of 3,3′,4,4′,5,5′-Hexahydroxy-trans-Stilbene Against Respiratory Syncytial Virus},
  journal = {Viruses},
  year = {2025},
  doi = {10.3390/v17101287}
}
Kostenlos starten →